Cargando…
Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells
OBJECTIVE: Breast cancer is one of the most significant causes of female cancer death worldwide. Although several chemotherapeutics have been developed to treat this type of cancer, issues remain such as low survival rates and high reoccurrence after chemotherapy and radiotherapy. To explore a chemo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555536/ https://www.ncbi.nlm.nih.gov/pubmed/28610415 http://dx.doi.org/10.22034/APJCP.2017.18.5.1283 |
_version_ | 1783256935318945792 |
---|---|
author | Maasomi, Zahra Javan Soltanahmadi, Younes Pilehvar Dadashpour, Mehdi Alipour, Shahriar Abolhasani, Somayeh Zarghami, Nosratollah |
author_facet | Maasomi, Zahra Javan Soltanahmadi, Younes Pilehvar Dadashpour, Mehdi Alipour, Shahriar Abolhasani, Somayeh Zarghami, Nosratollah |
author_sort | Maasomi, Zahra Javan |
collection | PubMed |
description | OBJECTIVE: Breast cancer is one of the most significant causes of female cancer death worldwide. Although several chemotherapeutics have been developed to treat this type of cancer, issues remain such as low survival rates and high reoccurrence after chemotherapy and radiotherapy. To explore a chemopreventive approach to enhancing breast cancer treatment efficacy, the antiproliferative effects of a combination of chrysin and silibinin, two herbal substances, in T47D breast cancer cells were assessed. MATERIALS AND METHODS: Cytotoxicity of the agents singly and in combination was evaluated by MTT assay. Also, qRT-PCR was used to measure the expression levels of hTERT and cyclin D1 genes after 48 h treatment. RESULTS: Cell viability assays revealed that chrysin or silibinin alone inhibited proliferation in a dose and time-dependent manner, and combining the drugs synergistically induced growth inhibition in the breast cancer cell line. The precise nature of this interaction was further analyzed by the median-effect method, where the combination indices (CI) were <1 for combination treatments, indicating synergism regarding T47D cell proliferation. qPCR results showed that the drug combination also synergistically down-regulated the mRNA levels of hTERT and cyclin D1 at all used concentrations compared with the drugs used alone after 48 h treatment (P ≤ 0.05). CONCLUSION: The data provide evidence that synergistic antiproliferative effects of Chrysin and Silibinin are linked to the down-regulation of cyclin D1 and hTERT genes, and suggest that their combination may have therapeutic value in treatment of breast cancer. |
format | Online Article Text |
id | pubmed-5555536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-55555362017-08-28 Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells Maasomi, Zahra Javan Soltanahmadi, Younes Pilehvar Dadashpour, Mehdi Alipour, Shahriar Abolhasani, Somayeh Zarghami, Nosratollah Asian Pac J Cancer Prev Research Article OBJECTIVE: Breast cancer is one of the most significant causes of female cancer death worldwide. Although several chemotherapeutics have been developed to treat this type of cancer, issues remain such as low survival rates and high reoccurrence after chemotherapy and radiotherapy. To explore a chemopreventive approach to enhancing breast cancer treatment efficacy, the antiproliferative effects of a combination of chrysin and silibinin, two herbal substances, in T47D breast cancer cells were assessed. MATERIALS AND METHODS: Cytotoxicity of the agents singly and in combination was evaluated by MTT assay. Also, qRT-PCR was used to measure the expression levels of hTERT and cyclin D1 genes after 48 h treatment. RESULTS: Cell viability assays revealed that chrysin or silibinin alone inhibited proliferation in a dose and time-dependent manner, and combining the drugs synergistically induced growth inhibition in the breast cancer cell line. The precise nature of this interaction was further analyzed by the median-effect method, where the combination indices (CI) were <1 for combination treatments, indicating synergism regarding T47D cell proliferation. qPCR results showed that the drug combination also synergistically down-regulated the mRNA levels of hTERT and cyclin D1 at all used concentrations compared with the drugs used alone after 48 h treatment (P ≤ 0.05). CONCLUSION: The data provide evidence that synergistic antiproliferative effects of Chrysin and Silibinin are linked to the down-regulation of cyclin D1 and hTERT genes, and suggest that their combination may have therapeutic value in treatment of breast cancer. West Asia Organization for Cancer Prevention 2017 /pmc/articles/PMC5555536/ /pubmed/28610415 http://dx.doi.org/10.22034/APJCP.2017.18.5.1283 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Research Article Maasomi, Zahra Javan Soltanahmadi, Younes Pilehvar Dadashpour, Mehdi Alipour, Shahriar Abolhasani, Somayeh Zarghami, Nosratollah Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells |
title | Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells |
title_full | Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells |
title_fullStr | Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells |
title_full_unstemmed | Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells |
title_short | Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells |
title_sort | synergistic anticancer effects of silibinin and chrysin in t47d breast cancer cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555536/ https://www.ncbi.nlm.nih.gov/pubmed/28610415 http://dx.doi.org/10.22034/APJCP.2017.18.5.1283 |
work_keys_str_mv | AT maasomizahrajavan synergisticanticancereffectsofsilibininandchrysinint47dbreastcancercells AT soltanahmadiyounespilehvar synergisticanticancereffectsofsilibininandchrysinint47dbreastcancercells AT dadashpourmehdi synergisticanticancereffectsofsilibininandchrysinint47dbreastcancercells AT alipourshahriar synergisticanticancereffectsofsilibininandchrysinint47dbreastcancercells AT abolhasanisomayeh synergisticanticancereffectsofsilibininandchrysinint47dbreastcancercells AT zarghaminosratollah synergisticanticancereffectsofsilibininandchrysinint47dbreastcancercells |